Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs17583995 | chr2:118719302 | T/C | 1.6E-5 | 178 | 25.17 | 30.93 | 11.65 | KM Plot |
PCPG | rs17584023 | chr2:118720852 | C/G | 1.6E-5 | 178 | 25.17 | 30.93 | 11.65 | KM Plot |
PCPG | rs17587254 | chr2:118841518 | A/G | 1.57E-5 | 178 | 25.28 | 26.62 | 11.65 | KM Plot |
PCPG | rs17609957 | chr17:50303110 | C/G | 3.24E-5 | 178 | 26.57 | 27.2 | 14.43 | KM Plot |
PCPG | rs17615989 | chr17:50303220 | C/T | 3.24E-5 | 178 | 26.57 | 27.2 | 14.43 | KM Plot |
PCPG | rs17627102 | chr12:21640214 | T/G | 2.39E-8 | 175 | 25.4 | 26.47 | 2.28 | KM Plot |
PCPG | rs1764483 | chr13:37613323 | T/C | 0.000294 | 178 | 4.17 | 24.7 | 25.7 | KM Plot |
PCPG | rs1764484 | chr13:37638050 | C/T | 0.000386 | 174 | 4.17 | 24.23 | 25.92 | KM Plot |
PCPG | rs1764486 | chr13:37639571 | T/C | 0.000355 | 176 | 4.17 | 24.23 | 25.92 | KM Plot |
PCPG | rs1764487 | chr13:37641131 | T/C | 0.000356 | 174 | 4.17 | 24.23 | 26.27 | KM Plot |
PCPG | rs1764489 | chr13:37655042 | G/C | 0.000305 | 177 | 4.17 | 24.23 | 25.87 | KM Plot |
PCPG | rs1764490 | chr13:37655029 | T/G | 0.000305 | 177 | 4.17 | 24.23 | 25.87 | KM Plot |
PCPG | rs1764491 | chr13:37654833 | G/T | 0.000287 | 178 | 4.17 | 24.23 | 25.92 | KM Plot |
PCPG | rs1764492 | chr13:37654704 | C/A | 0.000287 | 178 | 4.17 | 24.23 | 25.92 | KM Plot |
PCPG | rs1764493 | chr13:37654535 | A/G | 0.000287 | 178 | 25.92 | 24.23 | 4.17 | KM Plot |